532 related articles for article (PubMed ID: 29709530)
1. Beliefs influencing community pharmacists' interventions with chronic kidney disease patients: A theory-based qualitative study.
Quintana-Bárcena P; Lalonde L; Lauzier S
Res Social Adm Pharm; 2019 Feb; 15(2):145-153. PubMed ID: 29709530
[TBL] [Abstract][Full Text] [Related]
2. Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.
Lalonde L; Quintana-Bárcena P; Lord A; Bell R; Clément V; Daigneault AM; Legris MÈ; Letendre S; Mouchbahani M; Jouini G; Azar J; Martin É; Berbiche D; Beaulieu S; Beaunoyer S; Bertin É; Bouvrette M; Charbonneau-Séguin N; Desrochers JF; Desforges K; Dumoulin-Charette A; Dupuis S; El Bouchikhi M; Forget R; Guay M; Lemieux JP; Morin-Bélanger C; Noël I; Ricard S; Sauvé P; Ste-Marie Paradis F
Am J Kidney Dis; 2017 Sep; 70(3):386-396. PubMed ID: 28663062
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical care research and education project: pharmacists' interventions.
Kassam R; Farris KB; Burback L; Volume CI; Cox CE; Cave A
J Am Pharm Assoc (Wash); 2001; 41(3):401-10. PubMed ID: 11372905
[TBL] [Abstract][Full Text] [Related]
4. Barriers and facilitators of medication reconciliation processes for recently discharged patients from community pharmacists' perspectives.
Kennelty KA; Chewning B; Wise M; Kind A; Roberts T; Kreling D
Res Social Adm Pharm; 2015; 11(4):517-30. PubMed ID: 25586885
[TBL] [Abstract][Full Text] [Related]
5. Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study.
Bereznicki B; Peterson G; Jackson S; Haydn Walters E; DeBoos I; Hintz P
J Clin Pharm Ther; 2011 Jun; 36(3):348-55. PubMed ID: 21545614
[TBL] [Abstract][Full Text] [Related]
6. Australian Community Pharmacists' Experience of Implementing a Chronic Kidney Disease Risk Assessment Service.
Gheewala PA; Peterson GM; Zaidi STR; Jose MD; Castelino RL
Prev Chronic Dis; 2018 Jun; 15():E81. PubMed ID: 29908050
[TBL] [Abstract][Full Text] [Related]
7. Community pharmacists' naloxone counseling: A theory-informed qualitative study.
Rawal S; Osae SP; Tackett RL; MacKinnon NJ; Soiro FD; Young HN
J Am Pharm Assoc (2003); 2023; 63(6):1743-1752.e2. PubMed ID: 37633453
[TBL] [Abstract][Full Text] [Related]
8. Practical evaluation of the drug-related problem management process in Swiss community pharmacies.
Krähenbühl JM; Kremer B; Guignard B; Bugnon O
Pharm World Sci; 2008 Dec; 30(6):777-86. PubMed ID: 18392732
[TBL] [Abstract][Full Text] [Related]
9. Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.
Semcharoen K; Supornpun S; Nathisuwan S; Kongwatcharapong J
Int J Clin Pharm; 2019 Aug; 41(4):880-887. PubMed ID: 31054061
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Management of Drug-Related Problems in Chronic Kidney Disease Patients by Severity Level: A Subanalysis of a Cluster Randomized Controlled Trial in Community Pharmacies.
Quintana-Bárcena P; Lord A; Lizotte A; Berbiche D; Lalonde L
J Manag Care Spec Pharm; 2018 Feb; 24(2):173-181. PubMed ID: 29384023
[TBL] [Abstract][Full Text] [Related]
11. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
[TBL] [Abstract][Full Text] [Related]
12. Audit of community pharmacists' prescribing interventions: Quality assessment of a newly reimbursed service.
MacKeigan LD; Dolovich L; Petrovic B; MacCallum L; Bojarski EA; Pojskic N
J Am Pharm Assoc (2003); 2018; 58(6):622-629. PubMed ID: 30190200
[TBL] [Abstract][Full Text] [Related]
13. Using the theory of planned behavior to investigate community pharmacists' beliefs regarding engaging patients about prescription drug misuse.
Fleming ML; Bapat SS; Varisco TJ
Res Social Adm Pharm; 2019 Aug; 15(8):992-999. PubMed ID: 30442574
[TBL] [Abstract][Full Text] [Related]
14. Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study.
Salgado TM; Moles R; Benrimoj SI; Fernandez-Llimos F
Int J Clin Pharm; 2012 Aug; 34(4):569-78. PubMed ID: 22538466
[TBL] [Abstract][Full Text] [Related]
15. Drug-related problems and the clinical role of pharmacists in inpatient mental health: an insight into practice in Australia.
Richardson TE; O'Reilly CL; Chen TF
Int J Clin Pharm; 2014 Oct; 36(5):1077-86. PubMed ID: 25108413
[TBL] [Abstract][Full Text] [Related]
16. Psychosocial factors associated with pharmacists' antidepressant drug treatment monitoring.
Lauzier S; Guillaumie L; Humphries B; Grégoire JP; Moisan J; Villeneuve D
J Am Pharm Assoc (2003); 2020; 60(4):548-558. PubMed ID: 32173335
[TBL] [Abstract][Full Text] [Related]
17. Pharmacists' perceptions and communication of risk for alertness impairing medications.
Jomaa I; Odisho M; Cheung JMY; Wong K; Ellis JG; Smyth T; Saini B
Res Social Adm Pharm; 2018 Jan; 14(1):31-45. PubMed ID: 28118967
[TBL] [Abstract][Full Text] [Related]
18. Community pharmacists' views of using a screening tool to structure medicines use reviews for older people: findings from qualitative interviews.
Cardwell K; Hughes CM; Ryan C
Int J Clin Pharm; 2018 Oct; 40(5):1086-1095. PubMed ID: 29796962
[TBL] [Abstract][Full Text] [Related]
19. Drug-related problems among community-dwelling older adults in mainland China.
Yang J; Meng L; Liu Y; Lv L; Sun S; Long R; Shan X; Song J; Qiu F
Int J Clin Pharm; 2018 Apr; 40(2):368-375. PubMed ID: 29340850
[TBL] [Abstract][Full Text] [Related]
20. Pharmacists' role in handling problems with prescriptions for antithrombotic medication in Belgian community pharmacies.
Desmaele S; De Wulf I; Dupont AG; Steurbaut S
Int J Clin Pharm; 2015 Aug; 37(4):656-68. PubMed ID: 25822042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
